Blend Labs officer sells 74.7K shares at $1.43

A Blend Labs product technology officer sold 74,705 Class A shares under a pre-set Rule 10b5-1 trading plan, retaining 236,563 shares afterward.

Available on EDGAR 09/15/2026 - 05:01 PM EDT Accepted by SEC EDGAR 09/15/2026 - 05:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) reported that officer Venkatramani Srinivasan, Head of Product Tech & Customer Operations, sold 74,705 shares of Class A common stock on September 11, 2026 in an open-market transaction at a weighted average price of about $1.43 per share, with individual prices ranging from $1.40 to $1.455. Following this sale, he held 236,563 shares directly, and the transaction was carried out under a Rule 10b5-1 trading plan adopted on June 12, 2026.

Insider Trade Summary 10b5-1

Net Seller: 74,705 shares

Net Sell 1 txn

Insider Venkatramani Srinivasan

Role Head of Product Tech & Cust Op

Sold 74,705 shs ($107K)

Share of Position Sold 24.0%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2	74,705	$1.43	$107K

Holdings After Transaction: Class A Common Stock — 236,563 shares (Direct)

Holdings Before and After: Class A Common Stock, 311,268 to 236,563 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
2. F2. This sale price represents the weighted average sale price of the shares sold ranging from $1.40 to $1.455 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Key Figures

Shares sold: 74,705 shares Weighted average sale price: $1.43 per share Sale price range: $1.40–$1.455 per share +2 more

5 metrics

Shares sold 74,705 shares Open-market sale of Class A common stock on September 11, 2026

Weighted average sale price $1.43 per share Average of sales between $1.40 and $1.455 per share

Sale price range $1.40–$1.455 per share Range of prices for the reported sale transaction

Shares held after transaction 236,563 shares Direct ownership by the officer after the September 11, 2026 sale

Rule 10b5-1 plan adoption date June 12, 2026 Date the trading plan governing these sales was adopted

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"This sale price represents the weighted average sale price of the shares sold ranging from $1.40 to $1.455 per share."

open market or private transaction market

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BLND report for Venkatramani Srinivasan?

Blend Labs reported that Venkatramani Srinivasan sold 74,705 shares of Class A common stock on September 11, 2026 in an open-market transaction, leaving him with 236,563 shares held directly after the sale.

At what price were the BLND shares sold in this Form 4 transaction?

The shares were sold at a weighted average price of about $1.43 per share, with individual sale prices ranging from $1.40 to $1.455 per share, according to the disclosure.

Was the BLND insider sale made under a Rule 10b5-1 trading plan?

Yes. The company disclosed that the reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Venkatramani Srinivasan on June 12, 2026.

How many BLND shares does the insider hold after this sale?

After the sale, Venkatramani Srinivasan directly held 236,563 shares of Blend Labs Class A common stock, as reported in the filing.

What role does the insider in this BLND Form 4 hold at the company?

The reporting person, Venkatramani Srinivasan, is an officer of Blend Labs and serves as Head of Product Tech & Customer Operations, according to the disclosure.

How many BLND shares in total were sold in this Form 4 transaction?

The filing reports a single sale transaction of 74,705 shares of Blend Labs Class A common stock on September 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Venkatramani Srinivasan

(Last) (First) (Middle)

7250 REDWOOD BLVD., SUITE 300

(Street)

NOVATO CALIFORNIA 94945

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Blend Labs, Inc. [ BLND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Head of Product Tech & Cust Op

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/11/2026		S(1)		74,705	D	$1.43(2)	236,563	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.

2. This sale price represents the weighted average sale price of the shares sold ranging from $1.40 to $1.455 per share. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Kostian Ciko, Attorney-in-fact	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)